Fidelity Investments
DYN icon

Fidelity Investments’s Dyne Therapeutics DYN Stock Holding History

Fidelity Investments’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$180M Sell
11,146,369
-60,631
-0.5% -$1.39M 0.01% 979
2026
Q2 		$249M Buy
11,207,000
+2,298,020
+26% +$42.7M 0.01% 833
2026
Q1 		$162M Buy
8,908,980
+2,339,059
+36% +$40.3M 0.01% 962
2025
Q4 		$129M Buy
6,569,921
+1,168,005
+22% +$22.1M 0.01% 1060
2025
Q3 		$68.3M Buy
5,401,916
+108,547
+2% +$1.24M ﹤0.01% 1329
2025
Q2 		$50.4M Buy
5,293,369
+98,075
+2% +$1.08M ﹤0.01% 1392
2025
Q1 		$54.3M Sell
5,195,294
-2,801,637
-35% -$40.1M ﹤0.01% 1325
2024
Q4 		$188M Sell
7,996,931
-1,029,766
-11% -$30.5M 0.01% 851
2024
Q3 		$324M Buy
9,026,697
+3,707,734
+70% +$148M 0.02% 638
2024
Q2 		$188M Buy
5,318,963
+2,100,570
+65% +$61M 0.01% 805
2024
Q1 		$91.4M Buy
3,218,393
+1,935,581
+151% +$43.8M 0.01% 1096
2023
Q4 		$17.1M Buy
1,282,812
+436,452
+52% +$4.26M ﹤0.01% 1680
2023
Q3 		$7.58M Sell
846,360
-52,932
-6% -$570K ﹤0.01% 1919
2023
Q2 		$10.1M Buy
899,292
+490,236
+120% +$5.78M ﹤0.01% 1858
2023
Q1 		$4.71M Sell
409,056
-165,064
-29% -$2.14M ﹤0.01% 2117
2022
Q4 		$6.65M Buy
574,120
+500,878
+684% +$5.8M ﹤0.01% 2034
2022
Q3 		$930K Buy
73,242
+409
+0.6% +$4.69K ﹤0.01% 2623
2022
Q2 		$500K Buy
72,833
+66
+0.1% +$455 ﹤0.01% 2846
2022
Q1 		$701K Buy
72,767
+55,567
+323% +$473K ﹤0.01% 2878
2021
Q4 		$205K Buy
+17,200
New +$242K ﹤0.01% 2953
2021
Q2 		– Sell
-211,483
Closed -$3.28M – 4387
2021
Q1 		$3.28M Buy
211,483
+93,883
+80% +$1.82M ﹤0.01% 2360
2020
Q4 		$2.47M Hold
117,600
– – ﹤0.01% 2361
2020
Q3 		$2.37M Buy
+117,600
New +$2.58M ﹤0.01% 2267

Other funds holding DYN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Fidelity Investments's DYN Position: Q3 2026 in Review

Fidelity Investments reduced its Dyne Therapeutics (DYN) stake by 0.54% in Q3 2026, selling an estimated $1.39M and leaving 11,146,369 shares worth $180M. The position accounts for 0.01% of the portfolio, ranked #979.

Fidelity Investments first reported a position in DYN in Q3 2020 and has held it in 23 quarters since. The position peaked at $324M in Q3 2024. 107 funds tracked by Wall St. Rank hold DYN as of Q3 2026.

  • Fidelity Investments held 11,146,369 shares of Dyne Therapeutics worth $180M as of Q3 2026.
  • Fidelity Investments sold 60,631 Dyne Therapeutics shares in Q3 2026, an estimated $1.39M.
  • Dyne Therapeutics made up 0.01% of Fidelity Investments's portfolio in Q3 2026, its #979 holding.
  • Fidelity Investments first reported a position in Dyne Therapeutics in Q3 2020 and has held it in 23 quarters since.
  • Fidelity Investments's Dyne Therapeutics position peaked at $324M in Q3 2024.
  • 107 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.

Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.